CompletedNCT05066308
Cannabidiol and brain inflammation in people with chronic back pain
About this title
Read the official source — NCT05066308Medication studyAges 18–75United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 4, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 69
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05066308
- Official title
Show the full official title
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including CBD.
Who was this study for?
Listed age limits: 18 years to 75 years.
